Chemours Valuation

<div class='circular--portrait' style='background:#FF9E01;color: white;font-size:4em;padding-top: 15px;;'>CH</div>
CC -- USA Stock  

Earning Report: February 13, 2020  

Chemours shows prevailing Real Value of $18.34 per share. The current price of the firm is $15.59. At this time the firm appears to be undervalued. This module approximates value of Chemours from analyzing the firm fundamentals such as Return On Equity of 0.0001  and Profit Margin of 0.0013  as well as examining its technical indicators and Probability Of Bankruptcy. In general, we favor to go long with undervalued instruments and to trade away overvalued instruments since at some point assets prices and their ongoing real values will blend.
January 24, 2020
Real Value
Chemours is moderately volatile asset. Calculation of real value of Chemours is based on 3 months time horizon. Increasing Chemours time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.

Valuation Drivers Correlation

Click cells to compare fundamentals   View All Correlations
Chemours Company Valuation Data Drivers
Net Income Per Employee    Enterprise Value    Market Capitalization    

Chemours Market Cap

Chemours Company is rated fifth in market capitalization category among related companies. Market capitalization of Specialty Chemicals industry is currently estimated at about 76.81 Billion. Chemours holds roughly 2.82 Billion in market capitalization claiming about 4% of equities listed under Specialty Chemicals industry.
Capitalization  Valuation  Workforce  Revenue  Total debt
Horizon     30 Days    Login   to change
Chemours Company is rated below average in price to earning category among related companies. It is rated second in beta category among related companies totaling about  0.32  of Beta per Price to Earning. The ratio of Price to Earning to Beta for Chemours Company is roughly  3.17 

Valuation Basics

Chemours Enterprise Value Fundamentals

Quick Ratio0.93
Earnings Quarterly Growth-72.40%
Revenue Growth-14.60%
Payout Ratio41.49%
Enterprise Value To Ebitda7.04
Earnings Growth-69.50%
Enterprise Value To Revenue1.14
Continue to Trending Equities. Please also try World Markets Correlation module to find global opportunities by holding instruments from different markets.
Company logos by clearbit